HomeOGN • NYSE
add
Organon & Co
Previous close
$11.18
Day range
$11.10 - $11.66
Year range
$10.94 - $23.10
Market cap
2.91B USD
Avg Volume
4.27M
P/E ratio
3.39
Dividend yield
9.91%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.59B | -0.38% |
Operating expense | 598.00M | 14.78% |
Net income | 109.00M | -80.04% |
Net profit margin | 6.85 | -79.95% |
Earnings per share | 0.90 | 2.27% |
EBITDA | 375.00M | -17.40% |
Effective tax rate | 15.50% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 675.00M | -2.60% |
Total assets | 13.10B | 8.65% |
Total liabilities | 12.63B | 4.13% |
Total equity | 472.00M | — |
Shares outstanding | 257.95M | — |
Price to book | 6.11 | — |
Return on assets | 5.76% | — |
Return on capital | 7.95% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 109.00M | -80.04% |
Cash from operations | 390.00M | -1.76% |
Cash from investing | -296.00M | -265.43% |
Cash from financing | -82.00M | -6.49% |
Net change in cash | -88.00M | -131.54% |
Free cash flow | 268.75M | -27.88% |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Founded
1923
Headquarters
Website
Employees
10,000
